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Introduction and Aims: Serratia marcescens (Sm) is an opportunistic pathogen in
patients with cystic ﬁbrosis (CF). CF patients acquire Sm infection mostly following
manipulative airway procedures in hospitals, through patient-to-patient contacts or
from the environment. This retrospective review aimed to present a case of an
outbreak of Sm detections at a paediatric CF centre.
Methods: Respiratory sampling, antibiotic susceptibility testing and antibiotic pre-
scribing guidance were assessed. All isolates of Sm were additionally characterised
by pulse ﬁeld gel electrophoresis (PFGE) to determine the strain relatedness.
Results: From April to July 2012 Sm was found in 5 patient’s airways’ samples
(mean age 9.8 yrs, range 2−19 yrs, Centre size 63 patients, no Sm detected before).
Three patients presented with pulmonary exacerbation and S. aureus, concomitantly.
All received eradication therapy with TMP-SMX for 14 days based on antibiotic
susceptibility. Treatment was repeated in 2 (40%) patients. Strict patient segregation
and hygiene measures were implemented. The isolates of Sm did not differ in
phenotypic and antibiotic susceptibility, but PFGE showed that all strains were
biologically different, thus excluding cross-infection among patients or acquisition
in the hospital. Patients therefore probably acquired Sm in a community-related
setting. All patients were Sm free 10 months after ﬁrst detection.
Conclusions: Sm infection is of great concern due to its increasing resistance to
antibiotics. Accurate identiﬁcation is important in deﬁning and managing outbreaks.
PFGE can be a useful tool for understanding the molecular epidemiology.
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Objectives: Prevotella spp. have been consistently identiﬁed in the lungs of
CF patients, by culture and culture-independent methodologies; however, their
contribution to CF lung infection remains unclear. This study aimed to investigate
the similarity of Prevotella spp. sequentially isolated from patients with CF, to
determine their persistence over time in the lung.
Methods: Isolates (n = 82) were cultured either at three month intervals from
CF patients (n = 12) when clinically stable or from patients (n = 6) pre- and post-
antibiotic treatment of an infective pulmonary exacerbation. Molecular typing of
isolates was carried out by pulsed ﬁeld gel electrophoresis (PFGE), following XbaI
digestion, and by random ampliﬁcation of polymorphic DNA (RAPD). Banding
patterns were compared and dendrograms constructed using UPGMA analysis using
the DICE coefﬁcient (Gel ComparII).
Results: Highly similar (>70%) within-patient banding patterns were observed for
sequential isolates in 10/18 patients when examined by either PFGE or RAPD.
In addition, highly similar (e.g. >94%) Prevotella spp. were isolated pre- and
post-treatment of an exacerbation. In the remaining patients, sequential Prevotella
isolates were not of the same species.
Conclusions: These results suggest that Prevotella spp. are persistent rather than
transient colonizers of the CF lung, as evidenced by the high degree of similarity
of sequential isolates. Although their role in infection has not been deﬁnitively
identiﬁed, they do not appear to be eradicated by current antibiotic regimens. Further
work is ongoing to investigate their potential routes of transmission and mechanisms
of persistence within the CF lung.
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Strains of the genera Pandoraea and Inquilinus grow slowly in small colonies
and have poor biochemical activity, thus posing species identiﬁcation problems.
Moreover, on diagnostic media, Pandoraea and Inquilinus strains can mimic
Burkholderia cepacia complex (Bcc) and Pseudomonas aeruginosa, respectively.
From the sputum of a CF patient who had not been previously colonized or infected
with Bcc, red small colonies typical for Bcc were cultured on diagnostic medium
(B. cepacia agar base, CM0995, OXOID): they were misidentiﬁed as B. cepacia
using API 20NE (bioMe´rieux). Under the strict rules for hospital infection control,
the patient could not easily acquire the strain nosocomially. PCR using primers
speciﬁc for the Pandoraea genus (PanF, PanR), P. apista, and P. pulmonicola
(AppuF) identiﬁed the isolate to the genus level and PCR with newly designed
16S rRNA primers (Pan 326, Pan 530) assigned it to the species P. apista. Mucoid
colonies cultured from the second CF patient imitated a previously recovered
mucoid strain of P. aeruginosa, but were impossible to identify by API 20NE
(bioMe´rieux). Using speciﬁc 16S rRNA primers (il 1d, il 1r) described in the
literature, the isolate was assigned to the species Inquilinus limosus. Both of the
above described strains were cultured, identiﬁed by MALDI-TOF MS, or repeatedly
ampliﬁed from patient samples. Even if their role in the pathogenesis or exacerbation
of the disease in general and in particular patients remains unclear, apart from the
transmissibility of Pandoraea strains, attention should be paid to the differentiation
of these strains from serious pathogens in CF patients.
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Objective: Non-tuberculous mycobacteria (NTM) are increasingly prevalent
pathogens in CF. Chronic Mycobacterium abscessus in particular is associated with
faster decline in FEV1. We report our experience of treating NTM in children.
Methods: Children with 2 growths of the same NTM on sputum or bronchoalve-
olar lavage >1 month apart from 1/12/2004 to 1/12/2010 were identiﬁed. Patient
notes were reviewed. The highest FEV1 12 months preceding the 1
st isolate and
12−24 months after were compared.
Results: 12 children were identiﬁed (7 female/5 male), Phe508del homozygous
(n = 11) who had median FEV1 85 (range 65−99)% and median age 12.8 (range
5.9−15) years when NTM was ﬁrst isolated. Species isolated were Mycobacterium
abscessus (n = 7), M. avium (n = 4) and M kansasii (n = 1). Those with M. avium
were treated with ethambutol, rifampicin and clarythromycin, with 1 patient be-
coming chronically colonised. The child with M. kansasii was not treated and had
no further isolates. Of the 7/12 children with M. abscessus, 5 became chronically
colonised. All children with M. abscessus were treated with oral clarythromycin,
ciproﬂoxacin and nebulised aminoglycoside/meropenum for 12 months. Children
with chronic M. abscessus continued long term oral and regular intravenous therapy.
Despite this those with chronic M. abscessus had a trend to greater decline in FEV1
than those who did not (n = 5, median −4.6 (range −0.8 to −16.3)%/year vs n = 7,
median −2.6 (range 1.3 to −11)%/year).
Conclusion: Mycobacterium abscessus is an increasing problem in children with
CF causing deterioration in lung function, but there is no consensus on initiation,
duration and most effective treatment.
